Evidence map›Paper›PMID 41111328›Full record

ArticleDalton transactions (Cambridge, England : 2003)2025

Comparative

Jan Grzelak, Martí Gich, Rafael T M de Rosales, Anna Roig, Juan Pellico

Abstract readComparative Study
In one paragraph

Article in Dalton transactions (Cambridge, England : 2003), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jan GrzelakInstitute of Materials Science of Barcelona (ICMAB-CSIC), Campus of the UAB, 08193 Bellaterra, Spain. jpellico@icmab.es.ORCID http://orcid.org/0000-0002-8404-0389
Martí GichInstitute of Materials Science of Barcelona (ICMAB-CSIC), Campus of the UAB, 08193 Bellaterra, Spain. jpellico@icmab.es.
Rafael T M de RosalesSchool of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.ORCID http://orcid.org/0000-0003-0431-0535
Anna RoigInstitute of Materials Science of Barcelona (ICMAB-CSIC), Campus of the UAB, 08193 Bellaterra, Spain. jpellico@icmab.es.ORCID http://orcid.org/0000-0001-6464-7573
Juan PellicoInstitute of Materials Science of Barcelona (ICMAB-CSIC), Campus of the UAB, 08193 Bellaterra, Spain. jpellico@icmab.es.ORCID http://orcid.org/0000-0003-2787-8641

Funding

Wellcome Trust
6 · The paper itself

Abstract

Particles at the nanometric-micrometric interface hold promise by combining the drug-loading capacity of microparticles with the systemic benefits of nanoparticles. We assess the

Indexed as

NanoparticlesAnimalsMicePositron-Emission TomographySilicon DioxideTissue DistributionSilicon Dioxide

Identifiers

PMID41111328
PMCPMC12536255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.